CytomX Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2020 | — | -80.1% | -64.5% |
| FY2021 | — | -164.6% | -164.4% |
| FY2022 | — | -194.7% | -190.8% |
| FY2023 | — | -6.4% | -0.6% |
| FY2024 | — | 18.1% | 23.1% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2020 | — | -80.1% | -64.5% |
| FY2021 | — | -164.6% | -164.4% |
| FY2022 | — | -194.7% | -190.8% |
| FY2023 | — | -6.4% | -0.6% |
| FY2024 | — | 18.1% | 23.1% |